Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results

Publication ,  Conference
Raman, SR; Man, KKC; Berard, A; Boukhris, T; Yang, Y-HK; Kubota, K; Nakamura, H; Su, C-C; Sturkenboom, MCJM; Wong, ICK
Published in: Pharmacoepidemiology and Drug Safety
August 1, 2016

Duke Scholars

Published In

Pharmacoepidemiology and Drug Safety

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2016

Volume

25

Start / End Page

239 / 240

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Pharmacology & Pharmacy
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Raman, S. R., Man, K. K. C., Berard, A., Boukhris, T., Yang, Y.-H., Kubota, K., … Wong, I. C. K. (2016). Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results. In Pharmacoepidemiology and Drug Safety (Vol. 25, pp. 239–240). WILEY-BLACKWELL.
Raman, Sudha R., Kenneth K. C. Man, Anick Berard, Takoua Boukhris, Yea-Huei Kao Yang, Kiyoshi Kubota, Hidefumi Nakamura, Chien-Chou Su, Miriam C. J. M. Sturkenboom, and Ian C. K. Wong. “Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results.” In Pharmacoepidemiology and Drug Safety, 25:239–40. WILEY-BLACKWELL, 2016.
Raman SR, Man KKC, Berard A, Boukhris T, Yang Y-HK, Kubota K, et al. Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results. In: Pharmacoepidemiology and Drug Safety. WILEY-BLACKWELL; 2016. p. 239–40.
Raman, Sudha R., et al. “Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results.” Pharmacoepidemiology and Drug Safety, vol. 25, WILEY-BLACKWELL, 2016, pp. 239–40.
Raman SR, Man KKC, Berard A, Boukhris T, Yang Y-HK, Kubota K, Nakamura H, Su C-C, Sturkenboom MCJM, Wong ICK. Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results. Pharmacoepidemiology and Drug Safety. WILEY-BLACKWELL; 2016. p. 239–240.

Published In

Pharmacoepidemiology and Drug Safety

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2016

Volume

25

Start / End Page

239 / 240

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Pharmacology & Pharmacy
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences